Martingale Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-89,498
Closed -$11.2M 950
2020
Q4
$11.2M Buy
89,498
+17,937
+25% +$2.01M 0.13% 168
2020
Q3
$7.26M Buy
+71,561
New +$7.3M 0.09% 189
2018
Q3
Sell
-17,810
Closed -$1.66M 1032
2018
Q2
$1.66M Sell
17,810
-997
-5% -$85.9K 0.02% 605
2018
Q1
$1.56M Buy
+18,807
New +$1.67M 0.02% 603

Other funds holding PRAH

Martingale Asset Management's PRAH Position: Q1 2021 in Review

Martingale Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 89,498 shares — an estimated $11.2M sold.

Martingale Asset Management first reported a position in PRAH in Q1 2018 and held it in 4 quarters. The position peaked at $11.2M in Q4 2020. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • Martingale Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Martingale Asset Management sold 89,498 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $11.2M.
  • Martingale Asset Management first reported a position in PRA Health Sciences, Inc. in Q1 2018 and held it in 4 quarters.
  • Martingale Asset Management's PRA Health Sciences, Inc. position peaked at $11.2M in Q4 2020.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Martingale Asset Management's 13F filing for Q1 2021, filed 13 May 2021.